Information Provided By: 
Fly News Breaks for August 28, 2019
RGEN
Aug 28, 2019 | 04:53 EDT
First Analysis analyst Steven Schwartz raised his price target for Repligen to $107 from $95 saying he's more confident in the company's outlook following investor meetings with management and a facility tour. Schwartz is more confident in Repligen's longer-term growth prospects "despite heading into a second half where key businesses will face difficult comparisons." He keeps an Outperform rating on the shares.
News For RGEN From the Last 2 Days
There are no results for your query RGEN
